Skip to main content

We Treat Hep C - Resources for Michigan Providers

providers test treat cure
Join the effort to eliminate Hep C in all Michiganders

Any provider with prescriptive authority can cure hepatitis C. Through the Michigan Department of Health and Human Services' We Treat Hep C Initiative, Medicaid and Healthy Michigan Plan beneficiaries living with hepatitis C can be cured at little to no cost regardless of the prescriber's specialty, patient's past or current use of alcohol or drugs, or liver damage.

Prior Authorization *Fibrosis Restrictions Patient Abstinence from Alcohol & Drugs Specialist Prescriber Age (Years)
MAVYRET®** (glecaprevir/pibrentasvir) Not required None Not required Not required 3+
Other non-preferred HCV DAAs Standard Medicaid clinical prior authorization form None Not required Not required Administration and dosage vary for each DAA. Please see full prescribing information.

*While liver fibrosis assessment is essential for all patients, submission of fibrosis score is no longer required for treatment coverage under Medicaid/Healthy Michigan plans.

** Providers should order the entire course of Mavyret® indicating an 8- or 12-week supply.

  • Specialty or retail pharmacies are authorized to dispense up to 102 days of therapy at a single time but default to dispensing in 4-week increments unless otherwise indicated.

Learn about Hepatitis C testing and treatment

FAQ - Frequently asked questions on We Treat Hep C, including clinical questions.

We Treat Hep C Clinician Newsletter (March 2024) - Clinical newsletter highlighting Michigan's statewide initiative to eliminate hepatitis C among Michigan Medicaid and Healthy Michigan Plan beneficiaries by removing barriers to curing hepatitis C, highlighting adult universal hepatitis C testing recommendations, and spotlighting Dr. Elaine Engelsman, a nurse practitioner specializing in the treatment of infectious diseases, including hepatitis C. 

We Treat Hep C Clinician Newsletter (July 2024) - Clinical newsletter highlighting the importance of testing for hepatitis C during pregnancy, perinatal hepatitis C testing recommendations, and spotlighting Dr. Jennifer Hoffman and Dr. Lori Burke, physicians offering comprehensive addiction medicine services (including hepatitis C treatment) and gynecologic care. 

We Treat Hep C Clinician Newsletter (November 2024) - Clinical newsletter highlighting the first FDA-approved point-of-care hepatitis C RNA test, upcoming hepatitis C webinars and new educational materials, and spotlighting Michelle Thorne, a nurse practitioner specializing in family medicine and hepatitis C treatment at Calhoun County Public Health Department.